Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity.
Cell
; 177(3): 556-571.e16, 2019 04 18.
Article
in En
| MEDLINE
| ID: mdl-30955881
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Dendritic Cells
/
CD4-Positive T-Lymphocytes
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Year:
2019
Type:
Article